+ Bookmark This Page    
Preferences  |  7:40 AM
  1. Home
  2. Latest Press Releases
  3. Submit Press Releases
  1. PR Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
 

Antibody - Latest News   antibody RSS

1 - 13 of 13 Press Releases   Recent Top Tags   All Time Top Tags
New Report "Monoclonal Antibody Therapeutics 2009-2024" available through Aarkstore Enterprise
Market growth, novel technologies and expansion into new therapeutic areas - our new report examines the significant commercial opportunities
2009-11-23, 20 views, By Aarkstore Enterprise
Novus Biologicals announces opening of European office
Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, is proud to announce the opening of their first European office in Cambridge, England.
2009-11-07, 111 views, By Chris Hebard
RayBiotech to Award Biomarker Discovery Grants
RayBiotech today announced the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services for protein biomarker discovery.
2009-09-24, 144 views, By RayBiotech, Inc.
Visiongain: Monoclonal Antibodies in Cancer Therapy 2009-2024 on reports-research.com
Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains.
2009-08-28, 111 views, By reports.research.com
GenScript to Attend 1st Annual International Congress of Antibodies
GenScript will sponsor the BIT Life Sciences’ 1st Annual International Congress of Antibodies (ICA). CEO Dr. Frank Zhang will give keynote speech to share thoughts on antibody drug development.
2009-05-24, 306 views, By Sally Wang/GenScript
GenScript Offers Free Bio-reagent Sample Bundles
GenScript offers high quality bundled bio-reagent samples to appreciate customers and assist in biology research under current tough economic condition.
2009-05-08, 429 views, By Sally Wang/GenScript
Immuron To Acquire Intellectual Property from Hadassah Medical Center
Immuron introduces an Oral Immune Modulation technology acquired from Hadassah. Technology could yield within 2-3 years an all- natural, side effect free approach to diseases including Metabolic Syndrome, Hepatitis C and Type II Diabetes.
2009-04-19, 724 views, By Immuron Limited
GenScript antibody service guarantees ELISA titer of 1:20000 and positive Western blot results
GenScript raises the quality standard for its antibody packages.
2008-10-16, 495 views, By GenScript Corp.
Conference on Recombinant Antibodies
Conference to be held at 22nd - 23rd January 2009, BSG Conference Centre, London, UK
2008-10-11, 636 views, By bharatbook.com
IRI To Launch MunoTM Boost - Immune System Booster
IRI Separation Technologies (TSX.V:IRI) is the manufacturer of a remarkable new dietary supplement that enhances the human body’s natural immune system through direct supplementation of actual antibodies.
2008-05-29, 635 views, By ResourceX
Lee Biosolutions Human Salivary Amylase production increased to meet worldwide demand
Lee Biosolutions’ extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements for IVD manufacturers and clinical researchers.
2007-11-14, 1035 views, By Lee Biosolutions
High Purity Human Ferritin Antigen and Polyclonal Antibodies from Lee Biosolutions
Lee Biosolutions, Inc. announces the increased production and availability of the highest purity affinity purified polyclonal Ferritin antibodies and native human ferritin antigens to the clinical research community and IVD manufacturers.
2007-11-14, 621 views, By Lee Biosolutions
Ferritin Antibody and Antigen Now Available from Lee Biosolutions
Affinity purified polyclonal anti-human antibody and human antigen available at LeeBio.com
2006-09-22, 820 views, By KolbeCo Marketing Resources

Page:
  • 1



  1. SiteMap
  2. Contact PR Log
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice